Cargando…
Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
Resistance to multiple antitumour drugs, mostly antibiotics or alkaloids, has been associated with a cellular plasma membrane P-glycoprotein (Pgp), causing energy-dependent transport of drugs out of cells. However, in many common chemotherapy resistant human cancers there is no overexpression of Pgp...
Autores principales: | Schuurhuis, G. J., Broxterman, H. J., de Lange, J. H., Pinedo, H. M., van Heijningen, T. H., Kuiper, C. M., Scheffer, G. L., Scheper, R. J., van Kalken, C. K., Baak, J. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977458/ https://www.ncbi.nlm.nih.gov/pubmed/1681887 |
Ejemplares similares
-
Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
por: Schuurhuis, G. J., et al.
Publicado: (1993) -
The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance.
por: Schuurhuis, G. J., et al.
Publicado: (1990) -
Cortisol is transported by the multidrug resistance gene product P-glycoprotein.
por: van Kalken, C. K., et al.
Publicado: (1993) -
Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
por: Versantvoort, C. H., et al.
Publicado: (1993) -
Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.
por: Broxterman, H. J., et al.
Publicado: (1990)